AI4MDR Revolutionizes Certification Work and Healthtech Compliance with AI-Driven Solutions
In the rapidly evolving health technology sector, navigating regulatory and certification processes can be a formidable…
Comparative test results proof unique performance of Orion´s TRH technology
Orion Medical and Dr. med. dent. Andreas Schwitalla, Professor of the Charité-Universitätsmedizin Berlin, cooperate in t…
Orion Medical enables 3D Printing in Precision Medicine
Orion Medical GmbH, founded in Cham, Switzerland in March 2022, is a manufacturing solutions provider for the medical de…
AG PolyMORE – Opening meeting
On 21 September 2021, the founding members of the expert panel AG PolyMORE met at ETH Zurich for the first consortium me…
Regulatory Thinking: Method Thinking Approach in Regulation and Certification - MedTECH, IVD, SaMD, Pharma and Drug
Regulatory Thinking describes a strategic regulatory approach developed by regulatorythinking.com as a inter-disciplinary regulatory strategy that knows existing rules, regulations, common specifications, standards and norms and laws, adapts them to future technologies, un-common healthcare settings or any new or unknown challenges, and applies them in the spirit of the <<original idea>>.
Hosted by RegulatoryExperts@ETHzürich: AG PolyMORE – Opening meeting
Zurich, 21.09.2021. On 21 September 2021, the founding members of the expert panel AG PolyMORE met at ETH Zurich for the first consortium meeting 2021. The meeting was hosted by RegulatoryExperts@ETHzürich. The aim of the meeting was to define the vision and the overall purpose of the expert group's work and to determine the next steps. During the meeting, QS International AG was also welcomed as a new member of the consortium.
Register now for the free “4C Accelerator Tübingen” of the Stiftung für Medizininnovationen, the Medical Innovations GmbH and the University of Tübingen
The participants can survey the life science-specific start-up topics of the 4C's and thus plan ahead. The early strategic consideration of possible complications in the 4C's creates the prerequisite for attaining the necessary maturity in the shortest possible time and for convincing investors.
stimOS GmbH´s patent for implant surface functionalization was awarded with “Patent of the week” by the Medical Device Community, DeviceMed
www.meddev.news: South-Germany R&D and material science company, stimOS GmbH has received a notice of allowance from the German Patent and Trademark Agency for additional patents and intelligent property protection of their patented, innovative Mimicking Bone Technology (MBT). This publication was good reason for stimOS’ unique technology, to be chosen as “patent of the week” by the editors of DeviceMed publications.
